Source link : https://yourblogdomain.com/2026/03/03/fda-expands-sogroya-approval-record-obesity-rates-in-kids-cushings-and-depression/
Source link : https://newshealth.biz/health-news/fda-expands-sogroya-approval-record-obesity-rates-in-kids-cushings-and-depression/ (MedPage Today) — The FDA expanded the indication of the long-acting growth hormone somapacitan (Sogroya) to include very young children with idiopathic short stature, short stature born small for gestational age, or growth failure associated… Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/120143 Author : Publish date : 2026-03-03 19:42:00 Copyright for syndicated content belongs […]
—-
Author : yourblogdomain
Publish date : 2026-03-03 21:07:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8